background swath


A Recession Unlike any Other

Does the size of a company's pensions affect its stock price?

The longest expansion in U.S. economic history ended in February. March ushered in a recession that will be unlike any other we have seen before. In the last five weeks, 26 million workers have filed for unemployment insurance. That’s more than the total number of jobs that were created in the entire decade-long expansion. The unemployment rate looks likely to surge from a 50-year low of 3.5% in February to 15 or 20% just two months later. This would be the highest unemployment rate since the Depression.

Never before has the economy experienced a sudden stop of such magnitude and global synchronization. In the average of the last five U.S. recessions dating back to 1973, real GDP contracted by 2.3% peak-to-trough, bottomed after four quarters and regained the pre-recession peak after seven quarters. In 2020, real GDP is expected to contract by 7-10% in the second quarter alone (approximately 28-40% annualized, though we don’t think it makes much sense to annualize the data in this context). The second quarter could very well be the worst quarter of economic growth in U.S. history, if it surpasses the 7% real GDP decline in the fourth quarter of 1933.

Ironically, the magnitude of the decline and the dizzying speed with which it has occurred make this recession less frightening to us from an economic perspective than it would be otherwise. This is not a normal business cycle recession. The economy did not overheat and cause a misallocation of resources that subsequently required purging. This is a voluntary economic shutdown in pursuit of a public health goal. If we can successfully address the public health crisis in a timely fashion (which remains far from certain at this point), it seems plausible that we will be able to reopen the economy and resume healthy growth.

That said, we do not expect a V-shaped recovery for the economy as a whole. Social distancing will only be relaxed gradually and with much geographic dispersion. Some individual cities or regions that have been relatively unaffected by the virus might exhibit V-shaped recoveries, but prudent sequencing of the reopening around the country will make the aggregate nationwide recovery appear more U-shaped. Even if we could somehow reopen the entire national economy all at once – say in the case of a miracle cure – an economic shock this severe is bound to have some lasting effects. You simply can’t put 26 million people out of work and shutter thousands of firms for two months without leaving scars. Policymakers are working hard to prevent otherwise sound businesses from falling into financial distress during the shutdown, but there are bound to be some bankruptcies. The aggressive fiscal response will take the federal deficit above 15% this year (its highest level since World War II), but a sharp decline in tax revenue is likely to put severe pressure on state and local budgets and cause some degree of fiscal tightening at the subnational level. Turmoil in the energy sector further complicates matters.  These factors will slow the pace of the recovery, but rest assured: the fundamental health of the U.S. economy remains far stronger than the catastrophe that will be reflected in the Q2-2020 data.

To download a PDF version, please click here.

Disclaimer: By accepting this material, you acknowledge, understand and accept the following:

This material has been prepared by NISA Investment Advisors, LLC (“NISA”). This material is subject to change without notice. This document is for information and illustrative purposes only. It is not, and should not be regarded as “investment advice” or as a “recommendation” regarding a course of action, including without limitation as those terms are used in any applicable law or regulation. This information is provided with the understanding that with respect to the material provided herein (i) NISA is not acting in a fiduciary or advisory capacity under any contract with you, or any applicable law or regulation, (ii) that you will make your own independent decision with respect to any course of action in connection herewith, as to whether such course of action is appropriate or proper based on your own judgment and your specific circumstances and objectives, (iii) that you are capable of understanding and assessing the merits of a course of action and evaluating investment risks independently, and (iv) to the extent you are acting with respect to an ERISA plan, you are deemed to represent to NISA that you qualify and shall be treated as an independent fiduciary for purposes of applicable regulation. NISA does not purport to and does not, in any fashion, provide tax, accounting, actuarial, recordkeeping, legal, broker/dealer or any related services. You should consult your advisors with respect to these areas and the material presented herein. You may not rely on the material contained herein. NISA shall not have any liability for any damages of any kind whatsoever relating to this material. No part of this document may be reproduced in any manner, in whole or in part, without the written permission of NISA except for your internal use. This material is being provided to you at no cost and any fees paid by you to NISA are solely for the provision of investment management services pursuant to a written agreement. All of the foregoing statements apply regardless of (i) whether you now currently or may in the future become a client of NISA and (ii) the terms contained in any applicable investment management agreement or similar contract between you and NISA.

Agree to Terms

Please review and accept the following to proceed. I have read and agree to the Terms of Use, Disclaimer, PSRX Disclaimer and Privacy Policy. I am either (i) an investment professional and an employee of an institutional investor, or a consultant to an institutional investor, or (ii) an employee of, or a student in, an institution of higher learning and I am involved in the study, research or teaching of subjects related to investments, finance, or economics. I reside in the United States or Canada. I understand that the information is not and should not be regarded as investment advice or as a recommendation regarding a course of action. By clicking “Accept” below, you hereby acknowledge, understand and accept the foregoing.